Fennec Pharmaceuticals (FENC)

• Market cap: $244M
• 1 day: -0.68%
• 5 days: 2.22%
• 1 month: -3.63%
• 3 months: 1.15%
• 6 months: 45.76%
• Year to date: 39.27%
• 1 year: 85.2%
• 5 years: 18.7%
• 10 years: -27%
• Sector: Healthcare
• Industry: Biotechnology

About: Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Employees: 32